Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
01 1Malladi Drugs & Pharmaceuticals Limited
02 1Fermion Oy
03 1Cambrex Profarmaco Milano Srl
04 1Centaur Pharmaceuticals Private Limited
05 1MYLAN LABORATORIES LIMITED
06 1Pharmacia and Upjohn Company LLC
07 1R.L.Fine Chem Private Limited
08 1Spectrum Laboratory Products, Inc.
09 2Tianish Laboratories Private Limited
01 3ALPRAZOLAM
02 5Alprazolam
03 2alprazolam
01 1Finland
02 5India
03 4U.S.A
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
NDC Package Code : 57218-312
Start Marketing Date : 2008-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
With Fermion, start the journey of your innovative API.
NDC Package Code : 12780-4630
Start Marketing Date : 1991-04-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12828-0040
Start Marketing Date : 1988-04-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64330-013
Start Marketing Date : 2007-08-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0009-5144
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71554-013
Start Marketing Date : 2019-05-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-0295
Start Marketing Date : 1993-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84206-0005
Start Marketing Date : 2024-07-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84206-0108
Start Marketing Date : 2015-01-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-634
Start Marketing Date : 2015-01-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ksalol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ksalol, including repackagers and relabelers. The FDA regulates Ksalol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ksalol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ksalol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ksalol supplier is an individual or a company that provides Ksalol active pharmaceutical ingredient (API) or Ksalol finished formulations upon request. The Ksalol suppliers may include Ksalol API manufacturers, exporters, distributors and traders.
click here to find a list of Ksalol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ksalol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ksalol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ksalol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ksalol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ksalol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ksalol suppliers with NDC on PharmaCompass.
We have 9 companies offering Ksalol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
